A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...

The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

A new report from the American Cancer Society shows 7 in 10 cancer patients are living at least 5 years post-diagnosis.

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...